--2024/Q4-- / 8.825M--
--2024/Q3-- / 8.046M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 22.630
- -0.240-1.05%
Close Aug 16 16:00 ET
- 23.134
- +0.504+2.23%
Post 20:01 ET
2.30BMarket Cap-4129P/E (TTM)
23.170High22.090Low1.06MVolume22.690Open22.870Pre Close23.81MTurnover1.05%Turnover RatioLossP/E (Static)101.58MShares39.01052wk High2.37P/B2.27BFloat Cap19.37052wk Low--Dividend TTM100.34MShs Float202.730Historical High--Div YieldTTM4.72%Amplitude9.180Historical Low22.507Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Q2 2024 Earnings Date
Currency：USDAug 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 19.16M | 6.96M | -12.20M |
| Miss Est. | +40.96% | -48.82% | -63.69% |
| EPS | -1.23 | -1.52 | -0.29 |
| Miss Est. | +12.39% | -8.57% | -23.94% |
Analyst Rating
Aug 13, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
